Search research articles
Contact Us
Filters
Showing results (81-90 of 199) with videos related to
Page
of 20
Sort By:
Blood
|
April 9, 2004
Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help
Hendrik Poeck, Moritz Wagner, Julia Battiany, et al.
Cancer Research
|
October 16, 2003
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer
Evelyn Hartmann, Barbara Wollenberg, Simon Rothenfusser, et al.
Clinical and Vaccine Immunology : CVI
|
August 25, 2006
Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium
Evelyn Hartmann, Hendrik Graefe, Anne Hopert, et al.
Oligonucleotides
|
December 13, 2006
Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles
Miren Kerkmann, Dirk Lochmann, Jörg Weyermann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 9, 2010
Monocyte-mediated inhibition of TLR9-dependent IFN-α induction in plasmacytoid dendritic cells questions bacterial DNA as the active ingredient of bacterial lysates
Jens M Poth, Christoph Coch, Nicolas Busch, et al.
Immunology
|
January 14, 2010
Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha
Isabelle Bekeredjian-Ding, Meike Schäfer, Evelyn Hartmann, et al.
Nucleic Acids Research. Supplement (2001)
|
September 27, 2003
Evaluating the immune responses stimulated by CpG oligodeoxynucleotides
Mieko Hayashi, Makoto Kuwahara, Miwa Ogata, et al.
European Journal of Immunology
|
December 17, 2013
Self-priming determines high type I IFN production by plasmacytoid dendritic cells
Sarah Kim, Vera Kaiser, Esther Beier, et al.
International Journal of Cancer
|
December 5, 2019
High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome
Dominik Wolf, Heidi Fiegl, Alain G Zeimet, et al.
Trials
|
June 13, 2022
Influence on study outcomes of an inpatient study by the behavior of the study staff (PINgPOng): study protocol for a randomized clinical trial
Martin Coenen, Ulrike Bingel, Matthias Zunhammer, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 199) with videos related to
Sort By:
Page
of 20
Blood
|
April 9, 2004
Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help
Hendrik Poeck, Moritz Wagner, Julia Battiany, et al.
Cancer Research
|
October 16, 2003
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer
Evelyn Hartmann, Barbara Wollenberg, Simon Rothenfusser, et al.
Clinical and Vaccine Immunology : CVI
|
August 25, 2006
Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium
Evelyn Hartmann, Hendrik Graefe, Anne Hopert, et al.
Oligonucleotides
|
December 13, 2006
Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles
Miren Kerkmann, Dirk Lochmann, Jörg Weyermann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 9, 2010
Monocyte-mediated inhibition of TLR9-dependent IFN-α induction in plasmacytoid dendritic cells questions bacterial DNA as the active ingredient of bacterial lysates
Jens M Poth, Christoph Coch, Nicolas Busch, et al.
Immunology
|
January 14, 2010
Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha
Isabelle Bekeredjian-Ding, Meike Schäfer, Evelyn Hartmann, et al.
Nucleic Acids Research. Supplement (2001)
|
September 27, 2003
Evaluating the immune responses stimulated by CpG oligodeoxynucleotides
Mieko Hayashi, Makoto Kuwahara, Miwa Ogata, et al.
European Journal of Immunology
|
December 17, 2013
Self-priming determines high type I IFN production by plasmacytoid dendritic cells
Sarah Kim, Vera Kaiser, Esther Beier, et al.
International Journal of Cancer
|
December 5, 2019
High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome
Dominik Wolf, Heidi Fiegl, Alain G Zeimet, et al.
Trials
|
June 13, 2022
Influence on study outcomes of an inpatient study by the behavior of the study staff (PINgPOng): study protocol for a randomized clinical trial
Martin Coenen, Ulrike Bingel, Matthias Zunhammer, et al.
Page
of 20